Sunesis Pharmaceuticals has appointed William Quinn as their new chief financial officer and senior vice president of Finance and Corporate Development.    Quinn most recently served as chief executive officer and co-founder of the private cancer immunotherapy company Bullet Biotechnology. While there, he partnered with multiple biopharma companies and universities, raised multiple round of equity and convertible debt funding, and oversaw early development of several products.    ...